MCG Minority-Based Community Clinical Oncology Program

Information

  • Research Project
  • 7489289
  • ApplicationId
    7489289
  • Core Project Number
    U10CA107586
  • Full Project Number
    5U10CA107586-05
  • Serial Number
    107586
  • FOA Number
    RFA-CA-07-26
  • Sub Project Id
  • Project Start Date
    8/27/2004 - 21 years ago
  • Project End Date
    5/31/2012 - 13 years ago
  • Program Officer Name
    MCCASKILL-STEVENS, WORTA J.
  • Budget Start Date
    9/4/2008 - 17 years ago
  • Budget End Date
    5/31/2009 - 16 years ago
  • Fiscal Year
    2008
  • Support Year
    5
  • Suffix
  • Award Notice Date
    9/4/2008 - 17 years ago

MCG Minority-Based Community Clinical Oncology Program

[unreadable] DESCRIPTION (provided by applicant): The MCG MB-CCOP is dedicated to making NCI-sponsored cancer treatment, prevention and symptom- control studies available to cancer patients and patients that are at risk for cancer in the Central Savannah River Area (CSRA) which consists of 13 East Georgia counties and 3 West Central South Carolina counties. The patient base in this cachment area has historically been about 40% African-American with an increasing small percentage of Asian and Hispanic patients. Affiliates are located in Northeast Georgia, Aiken, SC, and the Augusta VA Medical Center (located next to MCG). The incidence of cancer in the African-American population is well-documented to be higher in proportion to the population as compared to whites. By offering clinical trials from a variety of research bases covering multiple cancer sites, patients seen for cancer care at MCG and affiliates have made available to them the latest in cutting edge research. Add to that the new Cancer Research Center that has just opened at MCG and patients in the area have the finest cancer care available. At present, there are 19 adult treatment trials, 15 pediatric treatment trials with 1 pediatric cancer control trial and 13 prevention and symptom-control trials open to accrual. Eligible patients for treatment and symptom management trials are approached at their doctor visits to ascertain interest in participation. Depending on the prescribed methods of recruitment for each prevention study, healthy individuals may be recruited through advertisements, flyers, word of mouth, etc. (e.g. smoking cessation study). The Medical College of Georgia's MB-CCOP and its affiliates offer the latest cancer clinical trials sponsored by the National Cancer Institute for cancer treatment, prevention and symptom management. These trials offer access to the latest developments in cancer prevention and treatment to patients living in east central and northeast Georgia, west central South Carolina, veterans served by the Augusta VA Medical Center, as well as the medically underserved in our region. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    U10
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    550477
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    399
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NCI:550477\
  • Funding Mechanism
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MEDICAL COLLEGE OF GEORGIA (MCG)
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
  • Organization City
    AUGUSTA
  • Organization State
    GA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    30912
  • Organization District
    UNITED STATES